SOURCE: Rothman Research

Rothman Research

April 30, 2010 09:12 ET

Sneak-Peek in the Medical Instruments and Supplies Industry

JOHANNESBURG, SOUTH AFRICA--(Marketwire - April 30, 2010) - www.rothmanresearch.com -- The medical instrument and supplies industry in the U.S. and globally has a promising future as more and more surgeries are being performed due to the appearance of state-of-the-art technologies which promote less invasive surgical treatments. It is believed that over 15 million people have surgeries in the U.S. annually, and that this trend will be on the rise supported by the aging population and baby boomer demographic. "Plastic surgery is one of the growing trends in the United States, and people are eagerly considering these kinds of surgeries because new technologies help minimize a big psychological fear barrier, that of going under a knife. Surgery procedures are evolving toward less invasive methods," stated Jack Benassi of www.rothmanresearch.com, "and companies behind these innovative technologies are mostly found under the medical instruments industry. This current earnings season promises to hold a lot of surprises for this industry, both good and bad." 

* www.rothmanresearch.com is a source for investors seeking free information on the Medical Instruments & Supplies industry; investors are encouraged to sign up for free at http://www.rothmanresearch.com/index.php?id=6&name=Register.

Last Thursday, Baxter international reported positive earnings of $525 million, but lowered its financial guidance for 2010, causing a massive correction to its share price. Baxter announced that charges related to the healthcare reform and slower-than-expected sales of plasma-based drugs due to increased competitive environments will impact its revenue for the year. At the beginning of this week, Alcon posted its first quarter results with a 27% increase in profit, citing a boost in its prescription, surgical and consumer products sales. Boston Scientific Corporation (NYSE: BSX), which also reported its first quarter 2010 earnings at the start of this week, delivered poor results due to a one-time charge of $1.8 billion stemming from the recalls of its heart devices. The company posted a net loss of $1.58 billion.

*Direct & free downloadable report on Boston Scientific Corporation is available by signing up now at http://www.rothmanresearch.com/article/bsx/23497/Apr-30-2010.html

PerkinElmer Inc. (NYSE: PKI) is set to release its first quarter 2010 results on May 6th after market close.

*Complimentary downloadable research on PerkinElmer Inc. is accessible upon registration at http://www.rothmanresearch.com/article/pki/23498/Apr-30-2010.html

Companies looking for additional media or advertising services can call Blue Chip IR at 1-917-267-8836

About Rothman Research

Rothman Research brings independent company and sector research together, utilizing top financial advisors and investment tactics to provide you with a clear picture of investment opportunities.

Contact Information